In a paper published in the April 25, 2008 edition of the Lancet, data revealed that there was only a slight difference between the survival rates of people taking AIDS drugs who were monitored with laboratory tests and those who were not. The research was based on computer modeling, and while the results must be verified, they could influence how HIV patients across Africa and Asia are treated. As drugs to combat AIDS have been distributed in developing countries, some doctors worry that without lab monitoring, patients will either die earlier or develop drug resistance faster. But based on the evidence to date, that has not happened. Read more in this article from AP Medical Writer Maria Cheng.

Related Information

• Understandin Absolute CD4 and CD4 Percentage

• Some People Want Lower CD4 Counts

• Understanding HIV Tropism

Today's review will take a look at another HIV drug class; the Non-nucleoside Reverse Transcriptase Inhibitors or NNRTIs as they are know. The NNRTIs are another weapon in the fight against HIV. Used in conjunction with HIV drugs from other classes, the NNRTIs have proven to be an effective tool in the battle to stay healthy. But understanding your medications is the key to a successful regimen. Let's review the NNRTIs.

Related Information

• Review Our List of Free HIV Medication Online Courses

• HIV Medication Adherence Tips

• HIV Medication Fact Sheets